Global prevalence and burden of meal-related abdominal pain
BMC Medicine volume 20, Article number: 71 (2022)
Patients with disorders of gut-brain interaction (DGBI) report meal intake to be associated with symptoms. DGBI patients with meal-related symptoms may have more severe symptoms overall and worse health outcomes, but this subgroup has not been well characterized. We aimed to describe the global prevalence of meal-related abdominal pain and characterize this subgroup.
The data analyzed originated from the Internet survey component of the population-based Rome Foundation Global Epidemiology Study, completed in 26 countries (n = 54,127). Adult subjects were asked whether they had abdominal pain and how often this was meal-related. Respondents were categorized into “no,” “occasional,” and “frequent” meal-related abdominal pain groups based on 0%, 10–40%, and ≥50% of the pain episodes being meal-related, respectively. DGBI diagnoses, frequency of other GI symptoms, psychological distress, non-GI somatic symptoms, quality of life, and healthcare utilization were compared between groups. Mixed linear and ordinal regression was used to assess independent associations between psychological distress, non-GI somatic symptoms, quality of life, other GI symptoms, and meal-related abdominal pain.
Overall, 51.9% of the respondents reported abdominal pain in the last 3 months, and 11.0% belonged to the group with frequent meal-related abdominal pain, which included more females and younger subjects. DGBI diagnoses were more common in subjects with frequent meal-related abdominal pain, and the frequency of several GI symptoms was associated with having more frequent meal-related abdominal pain. Having meal-related abdominal pain more frequently was also associated with more severe psychological distress, non-GI somatic symptoms, and a poorer quality of life. The group with frequent meal-related abdominal pain also more often consulted a doctor for bowel problems compared to the other groups of meal-related abdominal pain.
Reporting frequent meal-related abdominal pain is common across the globe and associated with other GI and non-GI somatic symptoms, psychological distress, healthcare utilization, and a poorer quality of life. Individuals who frequently experience meal-related abdominal pain also more frequently fulfill the diagnostic criteria for DGBI. Assessing meal-related symptoms in all DGBI patients could be of major importance to improve and individualize symptom management.
Disorders of gut-brain interaction (DGBI) are diagnosed by a typical gastrointestinal (GI) symptom pattern, in the absence of alarm features or evidence of organic disease processes that can account for the symptoms, and after a minimal relevant clinical evaluation . According to the worldwide epidemiology study by Sperber et al., more than 40% of the global adult population can be diagnosed with a DGBI using the Rome IV criteria . It is therefore logical that these disorders are one of the leading causes for consultations in primary care [3, 4]. They negatively influence the quality of life of patients and have a high impact on healthcare costs [5,6,7].
The pathophysiology of DGBI is multifactorial and, to date, has remained only partly understood. Patients may have or experience motility disturbances, visceral hypersensitivity, altered gut microbiota, altered immune and mucosal functions, and psychosocial disturbances together with a disrupted interaction between the gut and the brain . More recently, food intolerance has been recognized as an important pathophysiological factor [8, 9].
Currently, there are no objective biomarkers available for DGBI. Therefore, diagnosing a patient with a DGBI can be done using the specific Rome IV criteria assessed with the Rome IV questionnaire . These criteria are based on clusters of symptoms derived from a factor analysis after ruling out an identifiable organic disease. The Rome Foundation has been drafting and updating these criteria for more than two decades. The organization characterizes DGBI based upon the anatomical subdivisions in the GI tract. The diagnostic criteria for several DGBI, including functional dysphagia, postprandial distress syndrome, and rumination syndrome, comprise meal-related symptoms . The diagnostic criteria for irritable bowel syndrome (IBS) do not include the presence of meal-related symptoms, although many patients with IBS report an association between food intake and symptom onset [11, 12]. Furthermore, a recent study indicated that 13% of the patients with IBS severely self-restrict and avoid certain foods . These IBS patients appear to represent a more severely affected patient group with a lower quality of life, a reduced caloric intake, and a lower intake of several nutrients. Thus, there are indications that DGBI patients who have meal-related symptoms constitute a distinct subgroup with specific symptom patterns, health outcomes, and pathophysiological alterations.
Although the meal-related factor remains incompletely understood, foods containing poorly absorbed short-chain carbohydrates, i.e., fermentable oligo-, di-, monosaccharides, and polyols (FODMAPs), fatty foods, coffee, alcohol, and hot spices have been identified as the most important dietary symptom triggers . Various diets are increasingly implemented as treatment options not only for patients with IBS, but also for patients with functional dyspepsia [15,16,17,18]. Between studies, efficacy rates of dietary interventions generally vary from 50 to 75%, indicating that only a subset of patients responds to the dietary treatment [18,19,20,21]. Unfortunately, the specific subgroup of DGBI patients suffering from meal-related symptoms who potentially benefit from dietary intervention is currently not sufficiently characterized. This makes identification of these patients and effectively relieving their symptoms with dietary interventions even more difficult.
Our aim for this study was to describe the global prevalence of meal-related abdominal pain. Furthermore, to characterize subjects with meal-related abdominal pain, we aimed to describe the association between the frequency of meal-related abdominal pain and other GI symptoms, DGBI diagnoses, psychological distress, quality of life, and healthcare utilization. We hypothesized that subjects who frequently experience meal-related abdominal pain have a more severe symptom pattern, a poorer quality of life, and a higher healthcare utilization.
Participants were originally recruited for the Rome Foundation Global Epidemiology Study, previously described in detail elsewhere [2, 22]. Initially, this study was set up to investigate the global prevalence of DGBI using household and Internet survey data originating from 33 countries worldwide. All subjects who completed the Internet survey of the epidemiology study were included in this particular analysis. For the Internet survey, Qualtrics (Provo, UT, USA), which is a global market survey company, was commissioned to provide a nationally representative general population sample in 26 countries (Argentina, Australia, Belgium, Brazil, Canada, China, Colombia, Egypt, France, Germany, The Netherlands, Israel, Italy, Japan, Mexico, Poland, Romania, Russia, Singapore, South Africa, South Korea, Spain, Sweden, Turkey, UK, and the USA). The individuals who were recruited to complete the survey had previously registered themselves to participate in online surveys, such as opinion polls and health studies. To avoid selection bias, the individuals were not informed that the purpose of the study was specifically to assess the prevalence of DGBI and GI symptoms, before giving electronic consent. Instead, the survey was broadly described as a health survey. The participants remained anonymous to the investigators throughout the process. Further information about the quota-based sampling method that was used and about the study population in general can be found elsewhere .
Within the study sample, we aimed to identify and characterize subjects with meal-related abdominal pain. We identified participants who reported experiencing abdominal pain by selecting respondents who did not answer “Never” on the question “In the last 3 months, how often did you experience pain anywhere in your abdomen?” The GI symptom assessed in this question is referred to here as “general abdominal pain.” Among the subjects who reported general abdominal pain, we focused on how frequently the general abdominal pain was meal-related. Participants reporting general abdominal pain were asked a second question: “How often did your pain start or get worse after eating a meal?” Answers were scored from 0% of the time with pain to 100% of the time with pain on an 11-point scale (10% steps, with no response options in between). Respondents were then categorized into three subgroups of meal-related abdominal pain: the “no” meal-related abdominal pain group (0% of the abdominal pain episodes were meal-related), the “occasional” meal-related abdominal pain group (10–40% of the abdominal pain episodes were meal-related), and the “frequent” meal-related abdominal pain group (≥50% of the abdominal pain episodes were meal-related). We used these specific cutoffs of the frequency of meal-related abdominal pain to make the variable more comprehendible, which makes the interpretation of results more relatable to daily life.
The Adult Rome IV Diagnostic Questionnaire and a self-reported checklist of organic diseases and surgeries that can cause GI symptoms were used to diagnose DGBI in the global study population. Participants with a self-reported history that could represent organic or structural reasons for their symptoms were excluded from all the Rome IV DGBI diagnoses. Subjects with a history of peptic ulcer disease were excluded from the esophageal, gastroduodenal, and biliary diagnoses; participants who reported diverticulitis or bowel resection were excluded from the bowel and anorectal diagnoses; and subjects reporting celiac disease, GI cancer, or inflammatory bowel disease (Crohn’s disease or ulcerative colitis) were excluded from all Rome IV DGBI diagnoses.
Besides using the Adult Rome IV Diagnostic Questionnaire for the validated assessment of DGBI diagnoses, the questionnaire was used to measure the frequency of individual GI symptoms. Apart from general abdominal pain and meal-related abdominal pain, the frequency of the following other GI symptoms were included in the analysis: sensation of a lump in the throat, retrosternal chest pain, heartburn, dysphagia, postprandial fullness, early satiety, epigastric pain and burning, nausea, vomiting, regurgitation, belching, bloating or abdominal distention, biliary pain, accidental leakage of stool, aching, pain or pressure in the rectum not associated with a bowel movement, hard/lumpy stool, <3 stools per week (without laxative medication or enema), stool straining, and feeling of incomplete emptying. These symptoms were assessed using one-item questions that were structured as follows: “In the last 3 months, how often did you have a specific symptom?” The answers were either reported on a 9-point Likert scale from zero (never) to eight (multiple times per day or all the time) or on an 11-point Likert scale from 0% of times or instances to 100% of the times or instances, in 10% steps.
Non-GI somatic symptoms were measured using the Patient Health Questionnaire (PHQ)-12, which is a modified version of the PHQ-15 excluding the three GI-related questions . Symptoms were measured on a scale from zero = “not bothered at all” to two = “bothered a lot” with a 2-week recall period. The total score (0–24) is created by summing up the separate symptom scores, with high sum scores representing a high non-GI somatic symptom burden. One item assessed menstrual cramps or other period problems. Therefore, women could generally have higher PHQ-12 sum scores.
Psychological distress was assessed using the PHQ-4 questionnaire which is a 4-item questionnaire measuring the amount of anxiety and depression symptoms in the past 2 weeks . Outcomes are scores ranging from zero = “not at all” to three = “nearly every day” that can be summed up to calculate an anxiety, a depression, and a psychological distress score. Higher sum scores represent more severe indications of psychological distress.
Quality of life
The Patient-Reported Outcomes Measurement Information System Global-10 (PROMIS Global-10) questionnaire was used to assess the general quality of life of the participants. Nine general statements about subjective quality of life, social, physical, and mental functioning and fatigue are rated by respondents on 5-point Likert scales, and the tenth question, about overall pain, on an 11-point Likert scale. The results are two total scores, one for physical and one for mental quality of life with high scores representing a good quality of life .
The study survey contained questions measuring healthcare utilization, medication use, and surgery history. One question that was used in our analyses assessed if the subjects had ever visited a doctor because of a bowel problem. The second question assessed what particular doctor the subjects consulted for a bowel problem. Possible answers included a general practitioner or family doctor, a gastroenterologist, a gynecologist, a surgeon, a folk healer or traditional healer, an ayurvedic doctor, a homeopathic doctor, a traditional Chinese medicine doctor, and a chiropractor.
Prevalence rates were pooled across countries to determine a general prevalence rate. For this purpose, Yang’s meta-prevalence method, which combines separate population survey prevalence estimates into an overall meta-prevalence estimate, was used .
Proportions and means with 95% confidence intervals (95% CIs) were calculated for the three groups of meal-related abdominal pain in tables and graphs. Hereby, we focused on demographic variables, DGBI diagnoses, healthcare utilization, and the frequency of other GI symptoms. Among the subjects from the three groups of meal-related abdominal pain, we also investigated the proportion of subjects who fulfill the diagnostic criteria for zero, one, two, three, or four DGBI. Within the group fulfilling zero, one, two, three, or four DGBI diagnoses, we calculated the proportion of subjects from the no, occasional, and frequent meal-related abdominal pain group. To describe and summarize the data in this manner, no statistical tests were performed.
To be able to draw conclusions from the collected data, mixed ordinal regression was then used to analyze the association between meal-related abdominal pain (dependent variable) and the frequency of other GI symptoms (a priori chosen independent variables of interest). Potential confounders that were added to the models included demographical variables (age, gender, education, BMI) and psychological distress. A base model with the confounding variables was constructed and each GI symptom frequency was then individually added to the base model (Additional file 1: Table S1). Country was included as a random intercept effect to account for variability among countries. The intraclass correlation coefficient (ICC), when only including meal-related abdominal pain as the dependent variable and country as random intercept, was 0.014. The estimates of effect sizes of the independent variables were reported as odds ratios (ORs) and their 95% CIs. To give an example for interpretation of the ORs in ordinal regression, an OR of 1.4 for the continuous variable nausea (measured on a 11-point scale) means that the odds of having more frequent meal-related pain were increased by 1.4 for every unit increase in nausea. The proportional odds assumption for ordinal regression was in many cases not met. However, it was used for the analysis nonetheless as linear regression, beta regression, zero-inflated beta regression, and zero-inflated negative binomial regression fitted the data poorly. This was evaluated with diagnostic plots of residuals using the “DHARMa” package  in R”. The package “ordinal”  was used for the mixed ordinal regression analysis and the code can be provided upon request.
In order to assess the association between meal-related abdominal pain and health outcomes such as non-GI somatic symptoms, psychological distress, and quality of life, mixed linear regression was used. Meal-related abdominal pain was added as an independent variable and the dependent variables included psychological distress, non-GI somatic symptoms, and physical and mental quality of life (each included separately in the models). Potential confounders were considered the same as described for the ordinal regression. Country was included as random intercept effect.
Variance inflation factors were used to assess multicollinearity which were low (<5) in all cases.
Analyses were carried out with R (version 4.1.1) and R Studio (version 1.3.1093).
Worldwide prevalence of frequent meal-related abdominal pain
As displayed in the flowchart, we found that 51.9% of the global population reported that they experienced abdominal pain and 48.1% never experienced abdominal pain in the last 3 months (Fig. 1). In total, 18.0% of the global population reported that if they experienced abdominal pain, it was never meal-related, 22.9% indicated that they occasionally had meal-related abdominal pain (10–40% of abdominal pain episodes), and 11.0% reported frequent meal-related abdominal pain (at least 50% of abdominal pain episodes). As shown in Fig. 2 and Table 1, differences across countries were apparent. In China, Singapore, and Italy, 5.0–6.9% of the population frequently experienced meal-related abdominal pain, whereas the prevalence rates were clearly higher in Turkey, South Korea, and Egypt (14.0–18.0%). Table 2 shows the demographic characteristics of the three subgroups based on the frequency of meal-related abdominal pain. The highest proportions of females and younger individuals were observed in the group with frequent meal-related abdominal pain, as compared to the other two groups. When looking at the different BMI groups and education levels (as a proxy for socio-economic status), no major differences in proportion rates were found between the groups.
DGBI diagnoses of subjects grouped according to frequency of meal-related abdominal pain
Subjects with frequent meal-related abdominal pain were more likely to fulfill diagnostic criteria for DGBI than the subjects with no or occasional meal-related abdominal pain. For all DGBI, the proportion of subjects fulfilling DGBI diagnoses was larger in the frequent meal-related abdominal pain group compared to the other two groups (Table 3). Within the bowel disorders, the proportion of patients with frequent meal-related abdominal pain was highest in IBS. Functional dyspepsia (mainly the epigastric pain syndrome) and functional dysphagia were the gastroduodenal and esophageal disorders with the highest proportion of patients reporting frequent meal-related abdominal pain, respectively. For more details, see Table 3.
With an increasing number of DGBI diagnoses (within the main anatomical DGBI categories), a gradual increase in the proportion of subjects with frequent meal-related abdominal pain was noted (Fig. 3). Within the subgroup of individuals with four DGBI diagnoses, the proportion of subjects with frequent meal-related abdominal pain was higher than the proportion of subjects with occasional and no meal-related abdominal pain (66.5% vs. 28.9% vs. 4.5%, respectively).
Other GI symptoms associated with meal-related abdominal pain
The GI symptoms that occurred most frequently in all three meal-related abdominal pain groups were bloating or abdominal distention, postprandial fullness, and symptoms of constipation and diarrhea (Additional file 1: Table S2). The largest differences between the groups were seen for bloating or abdominal distention, postprandial fullness, biliary pain, early satiety, epigastric pain and burning, and symptoms of constipation and diarrhea.
In the unadjusted mixed ordinal regression, all of the GI symptoms had a strong association with meal-related abdominal pain (Additional file 1: Fig. S1). Experiencing general abdominal pain (OR = 3.77, 95% CI = 3.44–4.14), bloating or abdominal distention (OR = 2.61, 95% CI = 2.38–.87), a feeling of incomplete emptying (OR=2.42, 95% CI = 2.24–2.62), biliary pain (OR = 2.37, 95% CI = 2.19–2.57), and postprandial fullness (OR = 2.26, 95% CI = 2.09–2.46) corresponded to higher odds of having more frequent meal-related abdominal pain. In the adjusted analysis, age, gender, BMI, education (as a proxy for socio-economic status), and psychological distress were considered as possible confounders. After adjustment, the association of GI symptoms and meal-related abdominal pain was still considerable for the variables with the strongest associations seen for general abdominal pain (OR = 1.58, 95% CI = 1.56–1.61), epigastric pain and burning (OR = 1.57, 95% CI = 1.55–1.60), biliary pain (OR = 1.49, 95% CI = 1.47–1.51), nausea (OR = 1.40, 95% C I= 1.38–1.43), and regurgitation (OR = 1.38, 95% CI = 1.36–1.40) (Fig. 4).
Psychological distress, non-GI somatic symptoms, and quality of life associated with meal-related abdominal pain
More severe psychological distress was observed in the group with frequent meal-related abdominal pain compared to the other groups (Fig. 5a). Furthermore, the frequent meal-related abdominal pain group showed a higher burden of non-GI somatic symptoms compared to the two other groups (Fig. 5b), as well as a lower physical and mental quality of life (Fig. 5c, d).
The four separate mixed linear regression models indicated that psychological distress, non-GI somatic symptoms, and mental and physical quality of life were all strongly associated with the frequency of meal-related abdominal pain (Additional file 1: Table S3). After adjustment for demographical variables (age, gender, education, BMI) and psychological distress, the strength of the associations decreased for psychological distress, non-GI somatic symptoms, and physical quality of life (Table 4). The association between meal-related abdominal pain and poor mental quality of life diminished when the potential confounders were included in the model.
Healthcare utilization of subjects grouped according to frequency of meal-related abdominal pain
A higher proportion of subjects with frequent meal-related abdominal pain had consulted a doctor because of a bowel problem. Most subjects in the three groups visited a general practitioner/family doctor or a gastroenterologist for this purpose. Again, the proportion of subjects with frequent meal-related abdominal pain who used this healthcare service was higher than the proportion of subjects in the other two groups (Table 5).
To our knowledge, this is the first study to evaluate the global prevalence of frequent meal-related abdominal pain using the Rome IV questionnaire. We show that 11% of the adult global population frequently experiences meal-related abdominal pain. This subgroup is characterized by more females and a younger age. Subjects with frequent meal-related abdominal pain frequently fulfill the diagnostic criteria for several DGBI and more frequently use healthcare services for their bowel symptoms. It is, therefore, not surprising that having meal-related abdominal pain more frequently is independently associated with a higher frequency of having other GI symptoms. Subjects with frequent meal-related abdominal pain also have more severe psychological distress, as well as a higher burden of non-GI symptoms, and a lower physical and mental quality of life.
An overall meta-prevalence of 11% emphasizes that a substantial proportion of the global population experiences abdominal pain associated with meal intake. In this study, we focus on a meal-related GI symptom assessed by a single question. Comparing this 11% to a global prevalence rate of 40% for any DGBI would not be appropriate . However, it does indicate that even though not all individuals who experience meal-related abdominal pain fulfill the diagnostic criteria for a DGBI, a substantial proportion of the global population experiencing this meal-related symptom might need a suitable treatment approach.
The prevalence rates of meal-related abdominal pain ranged from 5.3% in Italy to 18.1% in Turkey. Previous research has shown that the global prevalence rates of DGBI in general vary widely across countries [2, 28,29,30]. In meta-analyses, differences in prevalence rates across countries and studies can be explained by methodological variances, such as using different diagnostic criteria [3, 29]. By performing this international multicenter study, the heterogeneity in methodology used between study centers was eliminated. However, differences in prevalence rates could still occur as a result of sociocultural factors [31,32,33]. When assessing meal-related abdominal pain, subjects’ perception of (abdominal) pain undoubtedly plays a role. Patients have symptom-related beliefs that influence how they handle the symptom experience and how they report symptoms [34, 35]. In addition, patients receive different healthcare services across the globe which also affects symptom-related beliefs . Furthermore, different cultural subgroups have different levels of literacy skills which could lead to difficulties understanding the study survey for some individuals . Linguistic differences across countries also occur yielding a difference in the interpretation and reporting of symptoms . Even in the same language, the same word can have a different meaning to different people. In India, people consume a fiber-rich diet and commonly have at least two to three bowel movements per day. When individuals consume a more Westernized diet, they could have only one bowel movement per day which might be interpreted and reported as constipation . Moreover, well-established Rome IV DGBI symptom patterns could differ between patients across the world. In China and India, the majority of the patients with IBS, defined as lower abdominal pain with altered bowel habits in Rome IV, report upper abdominal symptoms, such as bloating, dyspepsia, and epigastric pain relieved by defecation as their key symptom . Apart from the interpretation of symptoms, both dietary-related beliefs and dietary habits are of equal importance. We encounter different diets across the globe including the Western, Asian, Mediterranean, typical Australian diet, and many more. The Western dietary pattern contains a lot of ultra-processed foods, which are associated with symptom severity in patients with IBS and in turn most probably the prevalence of meal-related GI symptoms . In China, diet is believed to be crucial for a person’s health . According to the ancient Chinese wisdom, foods can be categorized into cold and hot foods. Both Chinese and Hispanics believe that diseases can be caused by an imbalance between cold and hot principles that are not related to temperature . Lastly, how we identify food as a potential symptom trigger is of importance. Dietary triggers may not always occur in the form of a meal. In the Adult Rome IV Diagnostic Questionnaire, specific food items, or substrates are not assessed as potential triggering factors. Consequently, we have to consider the potential differences in pathophysiological mechanisms behind meal- and food-related abdominal pain. Many specific food items or substrates, such as FODMAP-rich foods, spicy foods, and specific food antigens, i.e., wheat, yeast, milk, and soy, have been shown to exacerbate symptoms through many different pathophysiological mechanisms, such as incomplete absorption in the small bowel leading to water retention and gas formation in the large intestine, histamine-mediated responses, and local-immune reactions [8, 14, 44, 45]. Meal-related abdominal pain could very well be explained by similar mechanisms, but may also be linked to the caloric load of a meal and alterations in the expected GI motor response after meal intake. Therefore, how the trigger factor is defined in the assessment can influence outcomes. Hence, several factors related to the perception of symptoms, differences in diet, and views on food across the globe can potentially explain regional differences in frequency of meal-related abdominal pain.
When we study the characteristics of subjects who report frequently experiencing meal-related abdominal pain, we observe that more females and younger individuals belong to this subgroup. The majority of DGBI are more prevalent in females than in males with a female/male ratio of approximately 2:1 [3, 46]. Studies propose that the causes of these differences in prevalence rate between males and females are multifactorial and result from psychological [47, 48], social [49, 50], and biological factors, such as GI motility, [51, 52] autonomic tone , and central processing of visceral stimuli [54,55,56]. In regard to age and GI symptoms, most studies report that the prevalence of the majority of DGBI decreases with age . In addition, dietary patterns tend to differ between age groups, e.g., children and adolescents tend to have a higher intake of ultra-processed foods and fructose [57, 58]. We hypothesize that subjects who report frequently experiencing individual GI symptoms reflect similar demographic characteristics as individuals who fulfill diagnostic criteria for DGBI.
The proportion of the subjects in the frequent meal-related abdominal pain group who fulfill the diagnostic criteria for any DGBI was always higher compared to the other two groups. This could indicate that individuals with frequent meal-related abdominal pain represent a patient group with a more severe and diverse symptom pattern. A large proportion of the subjects who report frequently experiencing meal-related abdominal pain fulfill the diagnostic criteria for IBS. This finding was not unexpected since having abdominal pain (associated with altered bowel habits) is a required diagnostic criterion for IBS. However, we observe that a large proportion of subjects with frequent meal-related abdominal pain also fulfill the criteria for other DGBI, mainly DGBI that include other aspects of pain located in different parts of the body (e.g., epigastric pain syndrome and biliary pain) or other meal-related GI symptoms. It is perhaps not a surprise that having one type of pain comes with increased odds of other aspects of pain. However, it is still useful information to report when we aimed to characterize the symptom pattern and health outcomes of individuals who report meal-related abdominal pain. We observe a similar pattern in the co-existing symptoms of individuals with frequent meal-related abdominal pain. The symptoms that were strongly associated with meal-related abdominal pain included either a symptom aspect of pain or imply other symptoms that are related to food intake. Moreover, it has been shown that patients with overlapping DGBI and symptoms have increased disease severity, poorer quality of life, and increased use of healthcare services [22, 59]. We hypothesize that a large proportion of the individuals from the group with frequent meal-related abdominal pain represents this specific patient population with more severe health outcomes and diverse symptom patterns. When we look at the health outcomes in our analysis, a higher burden of psychological distress, more severe non-GI somatic symptoms, and a reduced quality of life were all independently associated with having meal-related abdominal pain more frequently. This might again be explained by the fact that patients with frequent meal-related abdominal pain experience a more severe symptom pattern that emphasizes the central role of the gut-brain axis in DGBI. The substantial decrease in effect size we noticed for the association with mental quality of life could potentially be explained by the effect of one of the confounding factors, psychological distress. We also found that subjects with frequent meal-related abdominal pain more often use healthcare services for bowel problems. Most likely patients who report meal-related symptoms could benefit from a multidisciplinary care approach including dietary and lifestyle advice and psychological and pharmacological therapy . This could make the treatment approach more efficient by targeting the burden of the non-GI somatic symptoms and psychological distress, the poor quality of life, and the diverse GI symptom pattern all at once.
The key strength of our study is the use of a global-reaching, uniformly collected dataset. The general population sampling was done with different quotas, allowing demographically balanced and population-representative samples with regard to age, gender, and education level. The initial epidemiology questionnaire study was collaboratively designed by a team of international DGBI experts, generating a very rich set of information focusing on the evaluation of all DGBI diagnoses using the latest diagnostic Rome IV criteria. All questionnaires were translated using a uniform translation method with cultural adaptations and linguistic validations. Quality checks were included in the online survey and the subsequent data processing to ensure that inconsistent and non-attentive responders could be eliminated from the analyses. Nevertheless, our study has several limitations. The first limitation is the cross-sectional nature of the data. It has been demonstrated that the severity of symptoms that patients with DGBI experience varies over time and that they can potentially shift between DGBI diagnoses depending on their symptom profile . In addition, despite the fact that we identified and excluded subjects with common doctor-diagnosed organic GI diseases (such as celiac disease, inflammatory bowel disease, cancer anywhere in the GI tract, peptic ulcer, and diverticulitis) from DGBI diagnoses, we could potentially have missed less common organic GI conditions that could explain the symptom profile. Furthermore, since the survey was conducted anonymously, we could not invite subjects to verify their clinical history or do medical tests to exclude alternative causes of the GI symptoms in our study cohort. This specific analysis assessing meal-related abdominal pain also included a specific limitation. The analysis and the categorization of subjects regarding the frequency of meal-related abdominal pain were based on a single item in the survey. It could have been relevant to assess not only the frequency of the GI symptom, but in addition also the severity, burden and/or interference with daily life, and other meal-related symptoms apart from abdominal pain.
In conclusion, this study demonstrates that a substantial proportion of the worldwide population experiences frequent meal-related abdominal pain. Identifying these subjects in the general population is important to assess the magnitude of this problem. However, identifying them in clinical practice could also be of importance. This could allow clinicians to propose a management strategy that focuses more on meal-related issues, potentially involving the help of trained dieticians. In order to improve the management of these subjects, more studies investigating meal-related GI symptoms (beyond abdominal pain) are needed. This will help us to understand the complete symptom profile of this specific subgroup and enhance our understanding of the underlying pathophysiological mechanisms.
Availability of data and materials
The data that support the findings of this study are available from Rome Foundation Global Epidemiology Study, but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of the Rome Foundation Global Epidemiology Study.
- 95% CIs:
95% confidence intervals
Analysis of variance
Body mass index
Disorder(s) of gut-brain interaction
Functional gastrointestinal disorders
Fermentable oligo-, di-, monosaccharides, and polyols
Irritable bowel syndrome
Patient health questionnaire
Patient-Reported Outcomes Measurement Information System-10
Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV. Gastroenterology. 2016. https://doi.org/10.1053/j.gastro.2016.02.032.
Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study. Gastroenterology. 2021;160(1):99–114.e3.
Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(7):712–21.e4.
Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P. Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior. Am J Gastroenterol. 2008;103(5):1229–39 quiz 40.
Hahn BA, Yan S, Strassels S. Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom. Digestion. 1999;60(1):77–81.
Spiegel BM. The burden of IBS: looking at metrics. Curr Gastroenterol Rep. 2009;11(4):265–9.
Canavan C, West J, Card T. Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther. 2014;40(9):1023–34.
Simrén M, Månsson A, Langkilde AM, Svedlund J, Abrahamsson H, Bengtsson U, et al. Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion. 2001;63(2):108–15.
Bisschops R, Karamanolis G, Arts J, Caenepeel P, Verbeke K, Janssens J, et al. Relationship between symptoms and ingestion of a meal in functional dyspepsia. Gut. 2008;57(11):1495–503.
Schmulson MJ, Drossman DA. What is new in Rome IV. J Neurogastroenterol Motil. 2017;23(2):151–63.
Böhn L, Störsrud S, Törnblom H, Bengtsson U, Simrén M. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol. 2013;108(5):634–41.
Houghton LA, Lea R, Agrawal A, Reilly B, Whorwell PJ. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit. Gastroenterology. 2006;131(4):1003–10.
Melchior C, Algera J, Colomier E, Törnblom H, Simrén M, Störsrud S. Food avoidance and restriction in irritable bowel syndrome: relevance for symptoms, quality of life and nutrient intake. Clin Gastroenterol Hepatol. 2021. https://doi.org/10.1016/j.cgh.2021.07.004.
McKenzie YA, Bowyer RK, Leach H, Gulia P, Horobin J, O'Sullivan NA, et al. British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). J Hum Nutr Diet. 2016;29(5):549–75.
Algera J, Colomier E, Simrén M. The dietary management of patients with irritable bowel syndrome: a narrative review of the existing and emerging evidence. Nutrients. 2019;11(9):2162.
Duboc H, Latrache S, Nebunu N, Coffin B. The role of diet in functional dyspepsia management. Front Psychiatry. 2020;11:23.
Van Den Houte K. Symptoms and duodenal mucosal integrity of functional dyspepsia patients are improved by the low FODMAP diet. UEG J. 2021; (in press).
Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. 2014;146(1):67–75.e5.
Staudacher HM, Whelan K, Irving PM, Lomer MC. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet. 2011;24(5):487–95.
de Roest RH, Dobbs BR, Chapman BA, Batman B, O'Brien LA, Leeper JA, et al. The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study. Int J Clin Pract. 2013;67(9):895–903.
Böhn L, Störsrud S, Liljebo T, Collin L, Lindfors P, Törnblom H, et al. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology. 2015;149(6):1399–407.e2.
Sperber AD, Freud T, Aziz I, Palsson OS, Drossman DA, Dumitrascu DL, et al. Greater overlap of Rome IV disorders of gut-brain interactions leads to increased disease severity and poorer quality of life. Clin Gastroenterol Hepatol. 2021. https://doi.org/10.1016/j.cgh.2021.05.042.
Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002;64(2):258–66.
Kroenke K, Spitzer RL, Williams JB, Löwe B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. 2009;50(6):613–21.
at: PG-A. Available from: https://www.codetechnology.com/promis-global-10/.
Yang B. Meta prevalence estimates. Generating combined prevalence estimates from separate population surveys. NSW Department of Health, Center for Epidemiology and Research, 2007.
Hartig F. DHARMa: residual diagnostics for hierarchical (multi-level/mixed) regression models. R package version 0.4.3; 2021.
Ford AC, Marwaha A, Sood R, Moayyedi P. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut. 2015;64(7):1049–57.
Sperber AD, Dumitrascu D, Fukudo S, Gerson C, Ghoshal UC, Gwee KA, et al. The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review. Gut. 2017;66(6):1075–82.
El-Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther. 2004;19(6):643–54.
Schmulson M, Corazziari E, Ghoshal UC, Myung SJ, Gerson CD, Quigley EM, et al. A four-country comparison of healthcare systems, implementation of diagnostic criteria, and treatment availability for functional gastrointestinal disorders: a report of the Rome Foundation Working Team on cross-cultural, multinational research. Neurogastroenterol Motil. 2014;26(10):1368–85.
Sperber AD. The challenge of cross-cultural, multi-national research: potential benefits in the functional gastrointestinal disorders. Neurogastroenterol Motil. 2009;21(4):351–60.
Chang L, Toner BB, Fukudo S, Guthrie E, Locke GR, Norton NJ, et al. Gender, age, society, culture, and the patient’s perspective in the functional gastrointestinal disorders. Gastroenterology. 2006;130(5):1435–46.
Helman CG. Communication in primary care: the role of patient and practitioner explanatory models. Soc Sci Med. 1985;20(9):923–31.
Eisenberg L. Disease and illness. Distinctions between professional and popular ideas of sickness. Cult Med Psychiatry. 1977;1(1):9–23.
Salmon P, Peters S, Stanley I. Patients’ perceptions of medical explanations for somatisation disorders: qualitative analysis. BMJ. 1999;318(7180):372–6.
Zuckerman MJ, Guerra LG, Drossman DA, Foland JA, Gregory GG. Health-care-seeking behaviors related to bowel complaints. Hispanics versus non-Hispanic whites. Dig Dis Sci. 1996;41(1):77–82.
Spiegel BM, Bolus R, Agarwal N, Sayuk G, Harris LA, Lucak S, et al. Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials. Aliment Pharmacol Ther. 2010;32(10):1275–91.
Ghoshal UC, Abraham P, Bhatt C, Choudhuri G, Bhatia SJ, Shenoy KT, et al. Epidemiological and clinical profile of irritable bowel syndrome in India: report of the Indian Society of Gastroenterology Task Force. Indian J Gastroenterol. 2008;27(1):22–8.
Gwee KA, Lu CL, Ghoshal UC. Epidemiology of irritable bowel syndrome in Asia: something old, something new, something borrowed. J Gastroenterol Hepatol. 2009;24(10):1601–7.
Tap J, Störsrud S, Nevé BL, Cotillard A, Pons N, Doré J, et al. Gut microbiome, diet and symptom interactions in irritable bowel syndrome. bioRxiv. 2020:2020.02.25.964528.
Kleinman A, Eisenberg L, Good B. Culture, illness, and care: clinical lessons from anthropologic and cross-cultural research. Ann Intern Med. 1978;88(2):251–8.
Helman. Culture, health and illness. 5th ed: CRC Press; 2007. p. 512.
Fritscher-Ravens A, Schuppan D, Ellrichmann M, Schoch S, Röcken C, Brasch J, et al. Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome. Gastroenterology. 2014;147(5):1012–20.e4.
Barrett JS, Gearry RB, Muir JG, Irving PM, Rose R, Rosella O, et al. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther. 2010;31(8):874–82.
Lovell RM, Ford AC. Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis. Am J Gastroenterol. 2012;107(7):991–1000.
Simrén M, Abrahamsson H, Svedlund J, Björnsson ES. Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern. Scand J Gastroenterol. 2001;36(5):545–52.
Thakur ER, Gurtman MB, Keefer L, Brenner DM, Lackner JM. Gender differences in irritable bowel syndrome: the interpersonal connection. Neurogastroenterol Motil. 2015;27(10):1478–86.
Ali A, Toner BB, Stuckless N, Gallop R, Diamant NE, Gould MI, et al. Emotional abuse, self-blame, and self-silencing in women with irritable bowel syndrome. Psychosom Med. 2000;62(1):76–82.
Walker EA, Katon WJ, Roy-Byrne PP, Jemelka RP, Russo J. Histories of sexual victimization in patients with irritable bowel syndrome or inflammatory bowel disease. Am J Psychiatry. 1993;150(10):1502–6.
Rao SS, Sadeghi P, Beaty J, Kavlock R, Ackerson K. Ambulatory 24-h colonic manometry in healthy humans. Am J Physiol Gastrointest Liver Physiol. 2001;280(4):G629–39.
Sun WM, Read NW. Anorectal function in normal human subjects: effect of gender. Int J Colorectal Dis. 1989;4(3):188–96.
Tillisch K, Mayer EA, Labus JS, Stains J, Chang L, Naliboff BD. Sex specific alterations in autonomic function among patients with irritable bowel syndrome. Gut. 2005;54(10):1396–401.
Kern MK, Jaradeh S, Arndorfer RC, Jesmanowicz A, Hyde J, Shaker R. Gender differences in cortical representation of rectal distension in healthy humans. Am J Physiol Gastrointest Liver Physiol. 2001;281(6):G1512–23.
Berman S, Munakata J, Naliboff BD, Chang L, Mandelkern M, Silverman D, et al. Gender differences in regional brain response to visceral pressure in IBS patients. Eur J Pain. 2000;4(2):157–72.
Naliboff BD, Berman S, Chang L, Derbyshire SW, Suyenobu B, Vogt BA, et al. Sex-related differences in IBS patients: central processing of visceral stimuli. Gastroenterology. 2003;124(7):1738–47.
Vos MB, Kimmons JE, Gillespie C, Welsh J, Blanck HM. Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey. Medscape J Med. 2008;10(7):160.
Vandevijvere S, De Ridder K, Fiolet T, Bel S, Tafforeau J. Consumption of ultra-processed food products and diet quality among children, adolescents and adults in Belgium. Eur J Nutr. 2019;58(8):3267–78.
Aziz I, Palsson OS, Törnblom H, Sperber AD, Whitehead WE, Simrén M. The prevalence and impact of overlapping Rome IV-diagnosed functional gastrointestinal disorders on somatization, quality of life, and healthcare utilization: a cross-sectional general population study in three countries. Am J Gastroenterol. 2018;113(1):86–96.
Basnayake C, Kamm MA, Stanley A, Wilson-O'Brien A, Burrell K, Lees-Trinca I, et al. Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trial. Lancet Gastroenterol Hepatol. 2020;5(10):890–9.
Halder SL, Locke GR 3rd, Schleck CD, Zinsmeister AR, Melton LJ 3rd, Talley NJ. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology. 2007;133(3):799–807.
The authors thank all the country-specific principal investigators from the Rome Foundation Global Epidemiology Study for gathering the data.
The original Rome Foundation Global Epidemiology Study was funded, in part, by research grants from Ironwood, Shire, Allergan, and Takeda. The study in Malaysia was funded by the Fundamental Research Grant Scheme (FRGS) of the Ministry of Education of Malaysia (Reference: 203.PPSP.6171192). The study in Israel was funded by Takeda-Israel. The study in Romania was funded by the Romanian Society of Neurogastroenterology. None of the funders was involved in the planning, design, implementation, statistical analyses, or any other aspect of the study including preparation of the paper or knowledge of its contents. The present study was funded by the Swedish Research Council (grant 2018-02566), by grants from the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALFGBG-722331, ALFGBG-726561), and by the Faculty of Medicine, University of Gothenburg. CM has been awarded the UEG Research Award 2020 for her stay at The University of Gothenburg.
Guarantor of the article
Magnus Simrén, MD, PhD
Ethics approval and consent to participate
All participants provided electronic consent before completing the study survey. The study was reviewed and deemed exempt from IRB human subjects oversight due to the anonymity of the survey method, by the Biomedical Institutional Review Board of the University of North Carolina at Chapel Hill (UNC IRB application number: 16-2486), the institution that served as Data Coordination Center and collected the survey data electronically from subjects in all the countries surveyed.
Consent for publication
C.M. has served as a consultant/advisory board member for Kyowa Kirin, Norgine, Biocodex, MayolySpindler, Tillots, and Ipsen. S.S. has served as an advisory board member for Takeda and speaker for Viatris. H.T. has served as an advisory board member/consultant for Almirall and Shire. L.V.O. is assistant research professor of the KU Leuven Special Research Fund (Bijzonder Onderzoeksfonds, BOF). A.D.S. has served as a consultant for Lapidot Israel and AbbVie-Israel outside the submitted work. O.S.P. has received a research contract from the Rome Foundation during the conduct of the study and received a research contract from Glycom A/S and Royal DSM and personal fees from metaMe Health, outside the submitted work. J.T. has given scientific advice to Adare, AlfaWassermann, Allergan, Arena, Bayer, Christian Hansen, Clasado, Danone, Devintec, Falk, Grünenthal, Ironwood, Janssen, Kiowa Kirin, Menarini, Mylan, Neurogastrx, Neutec, Novartis, Noventure, Nutricia, Shionogi, Shire, Takeda, Theravance, Tramedico, Truvion, Tsumura, Zealand, and Zeria Pharmaceutical; received research support from Shire, Sofar, and Tsumura; and served on the Speakers Bureau for Abbott, Allergan, AstraZeneca, Janssen, Kyowa Kirin, Menarini, Mylan, Novartis, Shire, Takeda, Truvion, and Zeria Pharmaceutical, all outside the submitted work. M.S. has received grants and personal fees from Gkycom and Danone Nutricia Research; personal fees from Ironwood, Menarini, Biocodex, Adnovate, Arena, Tillotts, Kyowa Kirin, Takeda, Alimentary Health, AlfaSigma, and the Falk Foundation; and grants from Genetic Analysis AS, outside the submitted work. The remaining authors disclose no conflicts.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The frequency of having other GI symptoms is associated with having meal-related abdominal pain more frequently (Unadjusted multivariable regression model). Mixed ordinal regression models with frequency of meal-related pain (11-item scale, 0-100%) as outcome indicated that having meal-related abdominal pain more frequently was associated with having other GI symptoms more frequently. The frequency of all other GI symptoms questioned in the Adult Diagnostic Rome IV questionnaire were used as an independent variable for the separate mixed ordinal regression models. Country was included as random intercept effect to account for variability among countries. OR>1 correspond to higher odds of having meal-related abdominal pain more frequently. Table S1. Base model of the mixed ordinal regression*. Table S2. The degree of occurrence of other GI symptoms in subjects grouped by meal-related abdominal pain occurrence*. Table S3. Mixed linear regression unadjusted*.
About this article
Cite this article
Colomier, E., Melchior, C., Algera, J.P. et al. Global prevalence and burden of meal-related abdominal pain. BMC Med 20, 71 (2022). https://doi.org/10.1186/s12916-022-02259-7